Home / Safety & FAQ

Know before you start — safety matters

Tizaro is a powerful medicine. Medical verification before dispensing ensures it's only used where the benefit outweighs the risk.

Common side effects (usually early, dose-related)

  • 🤢 Nausea — most common, especially during early dose increases. Usually temporary.
  • 🌀 Vomiting or stomach upset — manage with smaller, slower meals
  • 🚽 Diarrhoea or constipation — common in first 4–8 weeks
  • 🍽 Reduced appetite — expected; not usually a concern but monitor nutrition
  • 💉 Injection site reactions — minor; rotate sites to manage

Who should NOT take Tizaro

  • ⛔ Personal or family history of medullary thyroid carcinoma (MTC)
  • ⛔ Multiple endocrine neoplasia syndrome type 2 (MEN 2)
  • ⛔ Type 1 diabetes or diabetic ketoacidosis
  • ⛔ Pregnancy or planned pregnancy
  • ⛔ History of severe pancreatitis (use with caution)
  • ⛔ Severe gastrointestinal disease
℞ Prescription Only

Why prescription verification exists

Tizaro is not a health supplement or over-the-counter diet aid. It is a prescription injectable with real, dose-dependent risks. Our verification process — requiring a prescription or valid hospital record before any order is confirmed — exists to protect you, not inconvenience you.

Self-prescribing or sourcing tirzepatide without medical oversight eliminates the monitoring, dose adjustment, and safety checks that make this medicine effective rather than harmful.

Monitoring recommended during treatment

  • 🩺 Regular HbA1c and fasting glucose checks
  • ⚖️ Weight and BMI tracking at every appointment
  • 🫁 Liver enzyme panel (especially with prior liver concerns)
  • 💊 Review of concurrent medications for interactions
  • 👁️ Ophthalmological review if diabetic retinopathy present
Frequently Asked Questions

Common questions about Tizaro

Tirzepatide has been studied in people with obesity without diabetes (SURMOUNT-1) and showed significant weight-loss results.
Most patients notice reduced appetite within 2–4 weeks, and measurable weight loss by weeks 4–8 weeks. Significant results (5%+ body weight) typically occur between months 1–6. The full effect unfolds over 12–18 months.
If within 4 days of your scheduled day, inject as soon as possible. If more than 4 days have passed, skip the missed dose and resume on your regular day the following week. Never double-dose. Consult your physician if you miss multiple doses.
Tizaro comes in a pre-filled autoinjector pen designed for self-administration. Your doctor or nurse will train you before your first dose. Family members or caregivers can also be trained to assist.
Clinical evidence shows most patients regain a proportion of lost weight after stopping, particularly if lifestyle changes and exercise aren't maintained. Treatment duration and exit strategy should be planned .
Store refrigerated at 2°C to 8°C. Do not freeze. A pen in current use may be kept below 30°C for up to 21 days. All orders from our verified channel are dispatched with cold-chain packaging.
Tizaro can be combined with other non-insulin agents. Combining with insulin or sulfonylureas requires close monitoring due to hypoglycaemia risk.
Message us on WhatsApp with your name, location, and prescribed dose. Send a clear photo of your valid prescription or hospital record. Our pharmacist reviews and confirms before any order is processed.

Ready, and have your documents on hand?

Start the verified ordering process on WhatsApp.

Go to Verified Ordering →
Order on WhatsApp